Vascular benefits of adding carvedilolCR to type2 diabetic patients on ACEI:effects on oxidative stress and inflammation
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2012
At a glance
- Drugs Carvedilol; Lisinopril
- Indications Hypertension
- Focus Biomarker; Pharmacodynamics
- 17 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Jun 2010 Planned end date changed from 1 May 2008 to 1 May 2013 as reported by ClinicalTrials.gov record.
- 23 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.